Fast Money Pops & Drops, February 8th (SVVS, TEVA, BDX, TSLA, MENT)


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


On

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

CNBC's Fast Money Pops & Drops, Brian Kelly said that he likes SAVVIS, Inc. (NASDAQ: SVVS) because of its expanding margins. SAVVIS, Inc. (SVVS) gained 3.43% in the regular trading session, and it added 0.45% in the after hours. Karen Finerman was disappointed with Teva's (NASDAQ: TEVA) current earnings and the outlook. She thinks that this stock is cheap, but she is not ready to jump in. Teva Pharmaceutical Industries Ltd (ADR) (TEVA) fell 5.38% today, and it closed at $52.02.Stephen Weiss said that Becton, Dickinson and Co. (NYSE: BDX) missed the revenue estimate. He added that you don't want to miss your revenue estimate when you are trading at your all time high. Becton, Dickinson and Co. (BDX) fell 5.38%, and closed at $81.03.Tim Seymour said that Tesla Motors Inc (NASDAQ: TSLA) jumped 6.16% today on the news that the government will offer a rebate of $7,500 to buyers of electric cars.Joe Terranova talked about Mentor Graphics Corporation (NASDAQ: MENT), which jumped 3.72% after Carl Icahn commented that this company should be put for sale. Joe Terranova thinks that a potential buyer will have to pay $2 billion for this company.
Posted In: CNBCLong IdeasShort IdeasFast MoneyMediaTrading IdeasApplication SoftwareBrian KellyHealth CareHealth Care EquipmentInformation TechnologyInternet Software & ServicesJoe TerranovaKaren FinermanPharmaceuticalsStephen WeissTim Seymour